Diagnosis and treatment of dyspepsia in the elderly.

Abstract:

:Although dyspeptic symptoms are very common, the vast majority of patients have modest symptoms and rarely seek medical advice. The major organic causes of dyspepsia are chronic peptic ulcer disease, gastro-oesophageal reflux disease and malignancy. Functional dyspepsia is very common. In the fit elderly patient, prompt investigation may be more appropriate than empirical treatment in view of the higher proportion of patients with organic disease and the likelihood of malignancy. The symptoms of peptic ulceration and gastro-oesophageal reflux disease are often atypical in the elderly population. Frail patients, especially those with multiple pathology, should be treated empirically in the first instance. Empirical treatment should be with histamine H2-receptor antagonists or prokinetic agents. Drug treatment is not always required in dyspepsia and should be avoided where possible, especially given the increased risk of drug interactions and poor compliance in the elderly. For those patients with documented non-malignant organic disease, the advent of the H2-receptor antagonists, proton pump inhibitors, prokinetic drugs and regimens which eradicate Helicobacter pylori means that treatment is almost always successful.

journal_name

Drugs Aging

journal_title

Drugs & aging

authors

Pound SE,Heading RC

doi

10.2165/00002512-199507050-00003

subject

Has Abstract

pub_date

1995-11-01 00:00:00

pages

347-54

issue

5

eissn

1170-229X

issn

1179-1969

journal_volume

7

pub_type

杂志文章,评审
  • Use of low-molecular-weight heparins and new anticoagulants in elderly patients with renal impairment.

    abstract::Elderly people with renal impairment are at high risk for venous thromboembolism (VTE) and acute coronary syndromes (ACS); however, they are also at increased risk for bleeding complications. Evidence-based data for the management of anticoagulation in elderly patients with severe renal impairment, in particular, are ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11586730-000000000-00000

    authors: Samama MM

    更新日期:2011-03-01 00:00:00

  • Changes in protein kinases in brain aging and Alzheimer's disease. Implications for drug therapy.

    abstract::There is ample evidence for the involvement of aberrant protein phosphorylation reactions in aging and age-associated neurological disorders. Alzheimer's disease (AD) in particular. The exact nature of this involvement, however, is not yet elucidated. In the brain tissue of AD patients, there are numerous examples of ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199506020-00006

    authors: Jin LW,Saitoh T

    更新日期:1995-02-01 00:00:00

  • Age-related changes in signal transduction. Implications for neuronal transmission and potential for drug intervention.

    abstract::Problems associated with aging will become one of the leading health dilemmas of the next century. Age-associated diseases, including those affecting the neuronal system, are increasing in frequency. Age-related deficiencies in the brain result in impaired motor functions, sleep, behaviour and cognitive functions. Goo...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199405050-00006

    authors: Fülöp T Jr,Seres I

    更新日期:1994-11-01 00:00:00

  • NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies.

    abstract:BACKGROUND:Several studies have suggested that NSAID use may modify the risk of developing Parkinson's disease (PD). OBJECTIVE:Our aim was to conduct a meta-analysis of observational studies evaluating NSAID use and the risk of PD. METHODS:We systematically searched MEDLINE (1966-November 2008), EMBASE (1980-November...

    journal_title:Drugs & aging

    pub_type: 杂志文章,meta分析,评审

    doi:10.2165/11316780-000000000-00000

    authors: Samii A,Etminan M,Wiens MO,Jafari S

    更新日期:2009-01-01 00:00:00

  • Management of secondary hyperparathyroidism in the elderly patient with chronic kidney disease.

    abstract::Patients with chronic kidney disease (CKD) are generally affected by secondary hyperparathyroidism (SHPT). High phosphate, low calcium and vitamin D deficiency represent the classical 'triad' involved into the pathogenesis of SHPT in renal insufficiency, in which downregulation of the parathyroid vitamin D receptor an...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200926060-00002

    authors: Cozzolino M,Gallieni M,Pasho S,Fallabrino G,Ciceri P,Volpi EM,Olivi L,Brancaccio D

    更新日期:2009-01-01 00:00:00

  • Current management strategies for hepatitis B in the elderly.

    abstract::Despite the availability of an efficient vaccine, chronic hepatitis B virus (HBV) infection remains a major public health problem worldwide. The World Health Organization estimates that there are still 350 million chronic carriers of the virus who are at risk of developing chronic hepatitis, liver cirrhosis and hepato...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200118100-00002

    authors: Merle P,Trépo C,Zoulim F

    更新日期:2001-01-01 00:00:00

  • Pharmacological Treatment of Post-Prostatectomy Incontinence: What is the Evidence?

    abstract::Urinary incontinence is a common and debilitating problem, and post-prostatectomy incontinence (PPI) is becoming an increasing problem, with a higher risk among elderly men. Current treatment options for PPI include pelvic floor muscle exercises and surgery. Conservative treatment has disputable effects, and surgical ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-016-0388-8

    authors: Løvvik A,Müller S,Patel HR

    更新日期:2016-08-01 00:00:00

  • Suitable Use of Injectable Agents to Overcome Hypoglycemia Risk, Barriers, and Clinical Inertia in Community-Dwelling Older Adults with Type 2 Diabetes Mellitus.

    abstract::The management of type 2 diabetes mellitus in older adults requires a comprehensive understanding of the relationship between the disease (medical) and the functional, psychological/cognitive, and social geriatric domains, to individualize both glycemic targets and therapeutic approaches. Prevention of hypoglycemia is...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-019-00706-4

    authors: Valencia WM,Florez HJ,Palacio AM

    更新日期:2019-12-01 00:00:00

  • Age-related endothelial dysfunction : potential implications for pharmacotherapy.

    abstract::Aging per se is associated with abnormalities of the vascular wall linked to both structural and functional changes that can take place at the level of the extracellular matrix, the vascular smooth muscle and the endothelium of blood vessels. Endothelial dysfunction is generally defined as a decrease in the capacity o...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200320070-00005

    authors: Matz RL,Andriantsitohaina R

    更新日期:2003-01-01 00:00:00

  • The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old.

    abstract:BACKGROUND AND OBJECTIVE:Inappropriate prescribing is an important and possibly preventable risk factor for adverse drug reactions (ADRs) in the elderly, and hospital-based studies have shown that a large proportion of admissions is a result of ADRs. However, little is known about how inappropriate drug use (IDU) affec...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/00002512-200522010-00005

    authors: Klarin I,Wimo A,Fastbom J

    更新日期:2005-01-01 00:00:00

  • Etidronic acid. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

    abstract::Etidronic acid is an orally and intravenously active bisphosphonate, which is believed to inhibit resorption of bone via a number of cellular mechanisms, including alteration of osteoclastic activity. In studies of patients with symptomatic Paget's disease, etidronic acid 5 to 20 mg/kg/day administered orally rapidly ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199405060-00006

    authors: Dunn CJ,Fitton A,Sorkin EM

    更新日期:1994-12-01 00:00:00

  • Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.

    abstract::Relaxation of the upper age limits for solid organ transplantation coupled with improvements in post-transplant survival have resulted in greater numbers of elderly patients receiving immunosuppressant drugs such as tacrolimus. Tacrolimus is a potent agent with a narrow therapeutic window and large inter- and intraind...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200522070-00001

    authors: Staatz CE,Tett SE

    更新日期:2005-01-01 00:00:00

  • Anticholinergic medications: an additional contributor to cognitive impairment in the heart failure population?

    abstract:BACKGROUND/OBJECTIVES:Patients with congestive heart failure (CHF) have a high prevalence of cognitive impairment and the association is multifactorial. In general, the burden of anticholinergic drugs has consistently been shown to be a risk factor for cognitive impairment in the elderly. The aim of this study was to a...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-014-0204-2

    authors: Shaukat A,Habib A,Lane KA,Shen C,Khan S,Hellman YM,Boustani M,Malik AS

    更新日期:2014-10-01 00:00:00

  • Issues in the perioperative management of the elderly patient with cardiovascular disease.

    abstract::The elderly patient may show normal physiological changes of the cardiovascular and respiratory systems that accompany aging, as well as features of intrinsic cardiac disease. The latter include: a past history of myocardial infarction or ischaemic heart disease; history of congestive cardiac failure; angina; arterial...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200219060-00003

    authors: Sear JW,Higham H

    更新日期:2002-01-01 00:00:00

  • Continuity and adherence to long-term drug treatment by geriatric patients after hospital discharge: a prospective cohort study.

    abstract:BACKGROUND:Increased life expectancy is associated with an increased prevalence of chronic diseases and drug consumption. Changes often occur in the medication regimen after hospitalization. The extent and nature of these changes and the adherence of elderly patients have not yet been fully investigated. OBJECTIVE:To ...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/00002512-200825100-00005

    authors: Mansur N,Weiss A,Hoffman A,Gruenewald T,Beloosesky Y

    更新日期:2008-01-01 00:00:00

  • Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.

    abstract::Advances in our understanding of the structure, function and distribution of nicotinic acetylcholine receptors in the CNS have provided the impetus for new studies examining the role(s) that these receptors and associated processes may play in CNS functions. Further motivation has come from the realisation that such r...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199711030-00005

    authors: Newhouse PA,Potter A,Levin ED

    更新日期:1997-09-01 00:00:00

  • Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.

    abstract::Lisinopril, the lysine analogue of enalaprilat, is a long-acting angiotensin converting enzyme (ACE) inhibitor which is administered once daily by mouth. The efficacy of lisinopril in reducing blood pressure is well established in younger populations, and many trials now show it to be effective in lowering blood press...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199710020-00006

    authors: Langtry HD,Markham A

    更新日期:1997-02-01 00:00:00

  • Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.

    abstract::Parkinson's disease (PD) is a chronic movement disorder typically coupled to progressive degeneration of dopaminergic neurons in the substantia nigra (SN). The treatments currently available are satisfactory for symptomatic management, but the efficacy tends to decrease as neuronal loss progresses. Neurotrophic factor...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-014-0160-x

    authors: Rodrigues TM,Jerónimo-Santos A,Outeiro TF,Sebastião AM,Diógenes MJ

    更新日期:2014-04-01 00:00:00

  • High prevalence of medication non-adherence in a sample of community-dwelling older adults with adult protective services-validated self-neglect.

    abstract:BACKGROUND:Medication non-adherence can exacerbate disease severity, leading to impairments that interfere with self-care activities in older adults, and, ultimately, death. Elder self-neglect is the most common report to Adult Protective Services (APS) across the USA and is a significant risk factor for early mortalit...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-012-0007-2

    authors: Turner A,Hochschild A,Burnett J,Zulfiqar A,Dyer CB

    更新日期:2012-09-01 00:00:00

  • Potentially inappropriate anticholinergic medication use in community-dwelling older adults: a national cross-sectional study.

    abstract:BACKGROUND:Inappropriate medications are often used in older adults despite their unfavourable risk-to-benefit profile. Although many of the medications in the American Geriatrics Society (AGS) Beers list are potentially inappropriate because of their anticholinergic properties, little is known regarding the nature and...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-015-0257-x

    authors: Kachru N,Carnahan RM,Johnson ML,Aparasu RR

    更新日期:2015-05-01 00:00:00

  • Improving Medication Adherence and Health Outcomes in Older Adults: An Evidence-Based Review of Randomized Controlled Trials.

    abstract:BACKGROUND:Poor medication adherence is a major public health problem in older adults often resulting in negative health outcomes. OBJECTIVE:The objective of this review was to provide an updated summary of evidence from randomized controlled studies to determine whether interventions aimed at improving medication adh...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-016-0433-7

    authors: Marcum ZA,Hanlon JT,Murray MD

    更新日期:2017-03-01 00:00:00

  • Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management.

    abstract::Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) usually affect adults and older populations. The well recognized clinical (i.e., granulomatosis with polyangiitis [GPA], microscopic polyangiitis, and eosinophilic GPA) and serological phenotypes (i.e., anti-MPO-ANCA, anti-PR3-ANCA and ANCA nega...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-018-0617-4

    authors: Berti A,Caporali R,Montecucco C,Paolazzi G,Monti S

    更新日期:2019-01-01 00:00:00

  • Statin treatment for older adults: the impact of the 2013 ACC/AHA cholesterol guidelines.

    abstract::The 2013 American College of Cardiology (ACC) and American Heart Association (AHA) practice guidelines for the treatment of blood cholesterol significantly changed the paradigm of how providers should prescribe statin therapy, especially for older adults. While the evidence supports statin therapy for older adults wit...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-014-0238-5

    authors: Weinberger Y,Han BH

    更新日期:2015-02-01 00:00:00

  • Characteristics of New-Onset and Chronic Sleep Medication Users Among Older Adults: A Retrospective Study of a US Medigap Plan Population using Propensity Score Matching.

    abstract:BACKGROUND:Prescription sleep medications are often utilized to manage sleep problems among older adults even though these drugs are associated with multiple risks. OBJECTIVE:The aim was to determine the prevalence and characteristics of new-onset compared to chronic sleep medication users and to examine factors assoc...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-018-0543-5

    authors: Musich S,Wang SS,Slindee LB,Saphire L,Wicker E

    更新日期:2018-05-01 00:00:00

  • Early detection of Parkinson's disease. Implications for treatment.

    abstract::Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide and is characterised by cardinal clinical features and specific pathological findings. It is possible to detect PD early on in the course of the disease, and certain laboratory studies may identify preclinical stages. Based on this...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199609030-00002

    authors: Di Paola R,Uitti RJ

    更新日期:1996-09-01 00:00:00

  • Secondary prevention of osteoporosis in Australia: analysis of government-dispensed prescription data.

    abstract:BACKGROUND:Osteoporosis is a common cause of disability and death in elderly men and women. Until 2007, Australian Government-subsidized use of oral bisphosphonates, raloxifene and calcitriol (1alpha,25-dihydroxycholecalciferol) was limited to secondary prevention (requiring x-ray evidence of previous low-trauma fractu...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/11318400-000000000-00000

    authors: Hollingworth SA,Gunanti I,Nissen LM,Duncan EL

    更新日期:2010-03-01 00:00:00

  • Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study.

    abstract:BACKGROUND AND OBJECTIVE:Multiple drug use is common among old, frail nursing home residents who are, as a consequence, susceptible to adverse effects and drug interactions. This study uses the updated Beers criteria for potentially inappropriate drug (PID) use in older adults to determine the extent and nature of PIDs...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/00002512-200825080-00005

    authors: Hosia-Randell HM,Muurinen SM,Pitkälä KH

    更新日期:2008-01-01 00:00:00

  • Did the introduction of a prospective payment system for nursing home stays reduce the likelihood of pharmacological management of secondary ischaemic stroke?

    abstract:BACKGROUND:Since 1998, a prospective payment system (PPS) for Medicare services provided by nursing homes in the US has been in operation. Concerns have been expressed that the PPS may affect the quality of care delivered to residents. This study evaluates the impact of the PPS on pharmacological secondary ischaemic st...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/00002512-200623010-00006

    authors: Lapane KL,Hughes CM

    更新日期:2006-01-01 00:00:00

  • Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.

    abstract::Giant cell arteritis (GCA) is an inflammatory vasculopathy that involves large- and medium-sized arteries and can cause vision loss, stroke and aneurysms. GCA occurs in people aged >50 years and is more common in women. A higher incidence of the disease is observed in populations from Northern European countries. Poly...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11592500-000000000-00000

    authors: Schmidt J,Warrington KJ

    更新日期:2011-08-01 00:00:00

  • Safety and efficacy of once-daily gastroretentive gabapentin in patients with postherpetic neuralgia aged 75 years and over.

    abstract:BACKGROUND:Treatment of postherpetic neuralgia (PHN) is more complicated in elderly patients, and multiple daily dosing, complex titration, and high incidences of adverse events can be limiting for many pharmacological treatment options. OBJECTIVE:The aim of this study was to determine whether the efficacy and tolerab...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-013-0126-4

    authors: Gupta A,Li S

    更新日期:2013-12-01 00:00:00